Global Hydrolyzed Placental Protein Market Size By Type (Pig Originated Placenta, Horse Originated Placenta), By Application (Cosmetics, Functional Food), By Region, And Segment Forecasts, 2023 to 203...

The Global Hydrolyzed Placental Protein Market was valued at USD 715 million in 2023 and is projected to reach USD 1.28 billion by 2031, growing at a CAGR of 7.5% from 2023 to 2031. Hydrolyzed placental protein is gaining traction due to its rich bioactive composition, making it highly desirable in dermatology, cosmetics, pharmaceuticals, and nutraceuticals. Its anti-aging, anti-inflammatory, and regenerative properties are propelling demand across skincare and wellness industries, especially as consumers seek more naturally derived, scientifically supported products.

Drivers:

1. Increasing Demand for Anti-Aging and Regenerative Skincare:

Hydrolyzed placental protein is rich in peptides, amino acids, and growth factors that promote collagen production, cell regeneration, and skin rejuvenation. This has fueled its popularity in anti-aging creams, serums, and treatments, particularly in Asia-Pacific markets.

2. Rising Consumer Awareness Toward Natural and Bioactive Ingredients:

Consumers are shifting toward products containing bioactive, non-synthetic ingredients. Hydrolyzed placental protein, often derived from human or animal placenta, offers a natural source of skin-repairing agents, aligning well with this trend.

3. Expansion in Nutraceutical and Therapeutic Applications:

Beyond cosmetics, hydrolyzed placental protein is being studied and utilized in therapeutic formulations for wound healing, tissue repair, and immune system enhancement, expanding its use across pharmaceutical and functional food sectors.

Restraints:

1. Ethical and Religious Concerns:

The use of human or animal placenta raises ethical, cultural, and religious sensitivities. This restricts adoption in certain regions and consumer segments, potentially hindering market penetration.

2. Regulatory Complexity:

Stringent regulatory frameworks surrounding human-derived products and concerns over contamination risks require rigorous quality control, certification, and clinical validation—challenges that can delay commercialization.

Opportunity:

1. Surge in Demand for Premium Cosmeceuticals:

The cosmeceutical industry is witnessing a significant shift toward functional skincare with scientifically backed ingredients. Brands integrating hydrolyzed placental protein in luxury and clinical-grade formulations can command premium pricing and customer loyalty.

2. Advancements in Biotechnological Extraction and Purification:

Innovation in enzymatic hydrolysis, fermentation, and purification techniques is making the extraction of placental proteins more efficient, safe, and scalable—unlocking new opportunities in both mass and specialized markets.

Market by System Type Insights:

By system type, the Animal-Derived Hydrolyzed Placental Protein segment dominated the market in 2023, favored for its availability and compatibility with cosmetic and pharmaceutical formulations. However, the Human-Derived Placental Protein segment is expected to witness the fastest growth, supported by high efficacy in clinical and regenerative medicine applications and increasing acceptance in medical aesthetics.

Market by End-use Insights:

The Cosmetics & Skincare segment accounted for the largest market share in 2023, driven by its widespread use in anti-aging, brightening, and moisturizing products. The Pharmaceutical segment is expected to grow significantly during the forecast period, owing to expanding applications in wound healing, immune modulation, and tissue repair.

Market by Regional Insights:

Asia-Pacific led the market in 2023, with countries like Japan, South Korea, and China driving demand through well-established beauty industries and cultural acceptance of placental-based products. North America is anticipated to show robust growth, backed by innovation in medical aesthetics and increasing consumer awareness. Europe remains steady with demand from cosmeceuticals, although regulatory frameworks influence product launches.

Competitive Scenario:

Key players in the global hydrolyzed placental protein market include Japan Bio Products Co., Ltd., CJT Global, BIOON, Bioprogen, Biocell Technology LLC, Bio-Sun Science Co., Ltd., and Cell Research Corporation. These companies are investing in R&D, certification, and ethical sourcing to enhance product safety and widen application across end-use sectors.

Scope of Work – Global Hydrolyzed Placental Protein Market

Key Market Developments:

2023: Japan Bio Products Co., Ltd. launched a new line of clinical-grade placental extract serums targeting dermatology clinics in Asia-Pacific.

2024: Cell Research Corporation announced a successful Phase II clinical trial of its hydrolyzed placental protein-based therapy for diabetic wound healing.

2025: BIOON entered a distribution partnership with a leading European luxury skincare brand to expand its cosmeceutical reach across the EU.

FAQs:

1) What is the current market size of the Global Hydrolyzed Placental Protein Market?

The market size stood at USD 715 million in 2023.

2) What is the major growth driver of the Global Hydrolyzed Placental Protein Market?

The growing demand for anti-aging and regenerative skincare products is the key driver.

3) Which is the largest region during the forecast period in the Global Hydrolyzed Placental Protein Market?

Asia-Pacific holds the largest share and is expected to maintain dominance throughout the forecast period.

4) Which segment accounted for the largest market share in the Global Hydrolyzed Placental Protein Market?

The Cosmetics & Skincare segment led the market in 2023.

5) Who are the key market players in the Global Hydrolyzed Placental Protein Market?

Key players include Japan Bio Products Co., Ltd., CJT Global, BIOON, Bioprogen, Biocell Technology LLC, and Cell Research Corporation.